Sun Pharmaceutical Industries jumps on inking pact with Bayer

18 Jan 2024 Evaluate

Sun Pharmaceutical Industries is currently trading at Rs. 1328.90, up by 29.65 points or 2.28 % from its previous closing of Rs. 1299.25 on the BSE.

The scrip opened at Rs. 1299.25 and has touched a high and low of Rs. 1331.75 and Rs. 1290.70 respectively. So far 82423 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1339.95 on 16-Jan-2024 and a 52 week low of Rs. 922.55 on 22-May-2023.

Last one week high and low of the scrip stood at Rs. 1339.95 and Rs. 1294.00 respectively. The current market cap of the company is Rs. 319351.48 crore.

The promoters holding in the company stood at 54.48%, while Institutions and Non-Institutions held 36.59% and 8.92% respectively.

Sun Pharmaceutical Industries has signed an agreement with Bayer to market and distribute a second brand of Finerenone in India. Finerenone, a patented medicine is indicated to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease associated with type 2 diabetes mellitus.

Under the terms of the agreement, Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa. Finerenone was first launched by Bayer under the brand name Kerendia in 2022.

Sun Pharmaceutical Industries is among the largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1804.95 -13.65 (-0.75%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×